ダウンロード数: 198
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
23_0051.pdf | 1.77 MB | Adobe PDF | 見る/開く |
タイトル: | 表在性膀胱腫瘍に対するMitomycin CとCytosine Arabinosideの併用注入療法 |
その他のタイトル: | COMBINATION CHEMOTHERAPY OF MITOMYCIN C AND CYTOSINE ARABINOSIDE IN THE INTRAVESICAL TREATMENT FOR SUPERFICIAL BLADDER TUMORS |
著者: | 吉田, 英機 斉藤, 豊彦 池内, 隆夫 丸山, 邦夫 今村, 一男 |
著者名の別形: | Yoshida, Hideki Saito, Toyohiko Ikeuchi, Takao Maruyama, Kunio Imamura, Kazuo |
発行日: | Jan-1977 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 23 |
号: | 1 |
開始ページ: | 51 |
終了ページ: | 57 |
抄録: | Intravesical combination chemotherapies of 20 mg of mitomycin C and 200 mg of cytosine arabinoside were performed in the sixteen patients with superficial bladder tumors. The clinical effects of these treatments were compared with the results of 6 cases with 400 mg of cytosine arabinoside alone (group 1), 27 cases with 20 mg of mitomycin C alone (group 2) and 20 cases with daily double trials of each of 20 mg of mitomycin C (group 3). The results were as follows. 1) Complete disappearances of tumors after a series of twenty times of these combination chemotherapies were found in 5 cases (31.3%), and the clinical effectiveness, complete disappearances and significant reductions of tumors, were found in 11 cases (68.7%). The clinical result of these combination chemotherapies was better than group 1 (33.3%) and group 2 (40.7%), and was as good as group 3 (80.0%). 2) No serious side-actions with the combination therapies were found. 3) We thought that the clinical effects on the bladder tumors were increased with these intravesical combination chemotherapies. |
URI: | http://hdl.handle.net/2433/122045 |
出現コレクション: | Vol.23 No.1 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。